Published in Br J Cancer on April 01, 1999
Glycogen synthase kinase 3 beta: can it be a target for oral cancer. Mol Cancer (2010) 1.59
Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin. Cell Cycle (2007) 0.93
p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing. Oncogene (2007) 0.90
Lack of association of the cyclin D1 G870A variation with oral carcinoma risk: Evidence from 2,404 subjects. Exp Ther Med (2012) 0.78
Evaluation of p16 hypermethylation in oral submucous fibrosis: A quantitative and comparative analysis in buccal cells and saliva using real-time methylation-specific polymerase chain reaction. South Asian J Cancer (2016) 0.75
Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data. Acta Otorhinolaryngol Ital (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
p21 is a universal inhibitor of cyclin kinases. Nature (1993) 15.55
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (1993) 13.68
A cell cycle regulator potentially involved in genesis of many tumor types. Science (1994) 13.00
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell (1997) 12.41
G1 phase progression: cycling on cue. Cell (1994) 11.62
Role of the INK4a locus in tumor suppression and cell mortality. Cell (1996) 11.41
p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature (1994) 10.95
The E2F transcription factor is a cellular target for the RB protein. Cell (1991) 9.62
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell (1994) 9.25
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell (1998) 8.99
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell (1998) 8.33
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell (1995) 7.34
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell (1993) 7.19
Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell (1989) 6.46
Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science (1993) 4.81
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (1995) 4.78
Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol (1996) 4.67
The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell (1991) 4.42
Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res (1995) 4.28
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (1995) 3.41
Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (1995) 3.39
Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature (1995) 3.32
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res (1996) 3.18
The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev (1993) 3.10
Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci U S A (1995) 3.08
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology (1992) 3.03
Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene (1993) 2.99
Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J (1995) 2.26
Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J (1994) 2.25
CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. Oncogene (1995) 2.23
Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene (1993) 1.99
p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res (1994) 1.95
Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4. Cancer Res (1994) 1.88
Complex structure and regulation of the P16 (MTS1) locus. Cancer Res (1995) 1.87
Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res (1994) 1.80
HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J (1996) 1.69
Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res (1995) 1.68
Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res (1998) 1.63
Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci U S A (1992) 1.58
Molecular characterization of the retinoblastoma susceptibility gene. Biochim Biophys Acta (1993) 1.55
Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF. Proc Natl Acad Sci U S A (1997) 1.51
E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products. Mol Cell Biol (1991) 1.41
Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene (1989) 1.41
Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res (1994) 1.40
Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene (1995) 1.39
Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res (1994) 1.33
Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene (1997) 1.22
Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res (1995) 1.17
Overexpression of cyclin D1 enhances gene amplification. Cancer Res (1996) 1.16
Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res (1995) 1.07
Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res (1994) 1.05
Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Oncogene (1997) 1.01
Presence of human papillomavirus sequences in tumour-derived human oral keratinocytes expressing mutant p53. Eur J Cancer B Oral Oncol (1995) 0.99
Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. Cell Growth Differ (1997) 0.99
The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene (1994) 0.96
Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma. Int J Cancer (1997) 0.93
Molecular biology of human oral cancer. Crit Rev Oral Biol Med (1996) 0.91
Mutations of the p16 gene in gliomas. Oncogene (1996) 0.89
Altered expression and activity of G1/S cyclins and cyclin-dependent kinases characterize squamous cell carcinomas of the head and neck. Int J Cancer (1997) 0.88
Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. Cancer Res (1997) 0.87
Point mutations can inactivate in vitro and in vivo activities of p16(INK4a)/CDKN2A in human glioma. Oncogene (1997) 0.87
Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects: a novel method of detection. Oral Oncol (1998) 0.82
Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells. Oncogene (1996) 0.80
CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene (1995) 0.76
Detection of p53 mutations in oral cancer samples using a sensitive PCR-based method. Biochem Soc Trans (1997) 0.76
Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet (1993) 3.84
Global epidemiology of areca nut usage. Addict Biol (2002) 3.15
Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care (2003) 3.03
Epidemic of asthma possibly related to thunderstorms. BMJ (1994) 2.74
Coloured inhalers. BMJ (1992) 2.18
Structural and functional conservation of the human homolog of the Schizosaccharomyces pombe rad2 gene, which is required for chromosome segregation and recovery from DNA damage. Mol Cell Biol (1994) 2.13
Risk factors for squamous cell carcinoma of the oral cavity in young people--a comprehensive literature review. Oral Oncol (2001) 2.12
The epidemiology of mouth cancer: a review of global incidence. Oral Dis (2000) 2.10
A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Dis (2011) 2.02
Trends and ethnic disparities in oral and oro-pharyngeal cancers in South Africa, 1992-2001. SADJ (2013) 2.00
The epidemiology of tongue cancer: a review of global incidence. Oral Dis (2000) 1.83
Management of cancers of the head and neck in the United Kingdom: questionnaire survey of consultants. BMJ (1997) 1.83
Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer (1989) 1.81
Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems. Antisense Nucleic Acid Drug Dev (1997) 1.72
Copper content in Areca catechu (betel nut) products and oral submucous fibrosis. Lancet (1997) 1.71
Alterations of bone marrow sinus endothelium induced by ionizing irradiation: implications in the homing of intravenously transplanted marrow cells. Blood Cells (1992) 1.65
The oral health consequences of chewing areca nut. Addict Biol (2002) 1.63
Molecular and biochemical characterization of xrs mutants defective in Ku80. Mol Cell Biol (1997) 1.62
Characterisation of Schizosaccharomyces pombe rad31, a UBA-related gene required for DNA damage tolerance. Nucleic Acids Res (1997) 1.62
Granular cell tumor. Clinical spectrum of the benign and malignant entity. Cancer (1987) 1.58
Expression of the tumour suppressor gene p53 in oral cancer. Br J Oral Maxillofac Surg (1992) 1.57
The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review. J Oral Pathol Med (2014) 1.56
Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev (2003) 1.56
Evidence for the presence of receptors for C3 and IgG Fc on human synovial cells. Arthritis Rheum (1980) 1.54
Molecular analysis of mutations in the CSB (ERCC6) gene in patients with Cockayne syndrome. Am J Hum Genet (1998) 1.53
Oral pyogenic granuloma as a complication of pregnancy and the use of hormonal contraceptives. Int J Gynaecol Obstet (1976) 1.53
The two-week wait cancer initiative on oral cancer; the predictive value of urgent referrals to an oral medicine unit. Br Dent J (2006) 1.50
The experiences of young oral cancer patients in Scotland: symptom recognition and delays in seeking professional help. Br Dent J (2010) 1.49
Oral cancer: experiences and diagnostic abilities elicited by dentists in North-western Spain. Oral Dis (2006) 1.47
Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res (2011) 1.47
Transplantation of marrow to extramedullary sites. Science (1968) 1.45
Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis (2000) 1.45
Re: national prevalence of oral HPV infection and related risk factors in the U.S. adult population. Oral Dis (2012) 1.45
Suppression of normal human hematopoiesis by cytomegalovirus in vitro. Exp Hematol (1993) 1.43
Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med (1994) 1.43
Unification of the "burst" and "linear" theories of periodontal disease progression: a multilevel manifestation of the same phenomenon. J Dent Res (2003) 1.43
Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer. Clin Oncol (R Coll Radiol) (2008) 1.43
High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer (1991) 1.41
'Trends in the incidence of oral carcinoma in Northern Ireland 1975-89'. Br Dent J (1993) 1.40
Action on smoking--opportunities for the dental team. Br Dent J (2000) 1.39
Curriculum survey on tobacco education in European dental schools. Br Dent J (2012) 1.38
Gelatinous transformation of bone marrow in prolonged self-induced starvation. Scand J Haematol (1976) 1.38
Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med (1996) 1.38
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet (1995) 1.37
An alarming lack of public awareness towards oral cancer. Br Dent J (1999) 1.37
The cost of acute asthma--how much is preventable? Health Trends (1991) 1.36
Mutations in the xeroderma pigmentosum group D DNA repair/transcription gene in patients with trichothiodystrophy. Nat Genet (1994) 1.35
Potential applications of anti-keratin antibodies in oral diagnosis. J Oral Pathol (1987) 1.33
Evaluation of an autofluorescence based imaging system (VELscope™) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol (2011) 1.31
Liver-derived fetal hematopoietic stem cells selectively and preferentially home to the fetal bone marrow. Blood (1993) 1.30
Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest (1994) 1.29
Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest (1992) 1.28
Mutant sequences in the rpsL gene of Escherichia coli B/r: mechanistic implications for spontaneous and ultraviolet light mutagenesis. Mol Gen Genet (1992) 1.27
Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996. J Oral Pathol Med (1999) 1.26
Molecular basis of the recognition of intravenously transplanted hemopoietic cells by bone marrow. Proc Natl Acad Sci U S A (1988) 1.25
The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med (1999) 1.25
Cancer of mouth, pharynx and nasopharynx in Asian and Chinese immigrants resident in Thames regions. Oral Oncol (1999) 1.25
Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer. Mol Ther (2006) 1.24
The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. Gastroenterology (1997) 1.24
Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med (2000) 1.23
Salivary gland neoplasms in Maiduguri, north-eastern Nigeria. Oral Dis (2005) 1.23
The influence of partial and full-mouth recordings on estimates of prevalence and extent of lifetime cumulative attachment loss: a study in a population of young male military recruits. J Periodontol (2001) 1.22
Synthetic neoglycoproteins: a class of regents for detection of sugar-recognizing substances. J Histochem Cytochem (1984) 1.20
Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet (1993) 1.19
Is early diagnosis of oral cancer a feasible objective? Who is to blame for diagnostic delay? Oral Dis (2010) 1.18
Microbial contamination of dental unit waterlines: the scientific argument. Int Dent J (1998) 1.15
Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med (2004) 1.15
Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity. J Virol (1996) 1.15
Inhibitory effect of salivary fluids on PCR: potency and removal. PCR Methods Appl (1994) 1.15
Increasing incidence of oral cancer amongst young persons: what is the aetiology? Oral Oncol (2000) 1.15
Copper stimulates human oral fibroblasts in vitro: a role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med (2001) 1.14
Smokeless tobacco and oral cancer. Oral Dis (2004) 1.13
Oral diseases and socio-economic status (SES). Br Dent J (2003) 1.11
Trichothiodystrophy, a human DNA repair disorder with heterogeneity in the cellular response to ultraviolet light. Cancer Res (1988) 1.11
Identification of the major surface protein antigens of Porphyromonas gingivalis using IgG antibody reactivity of periodontal case-control serum. Oral Microbiol Immunol (1991) 1.11
Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study. Thorax (2002) 1.10
Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutr Cancer (1997) 1.10
Relation between the human fibroblast strain 46BR and cell lines representative of Bloom's syndrome. Cancer Res (1988) 1.10
Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. J Immunol (1999) 1.10
Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res (1994) 1.10
Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol (2003) 1.09
Hemopoietic stromal microenvironment. Am J Hematol (1983) 1.09
Toombak use and cigarette smoking in the Sudan: estimates of prevalence in the Nile state. Prev Med (1998) 1.09
Liver endothelium and not hepatocytes or Kupffer cells have transferrin receptors. Blood (1984) 1.08
Prognostic significance of STNMP and velocity of tumor growth in oral cancer. Cancer (1982) 1.08
Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report. Cancer Gene Ther (2006) 1.07
Cellular relationship in the rat bone marrow studied by freeze fracture and lanthanum impregnation thin-sectioning electron microscopy. J Ultrastruct Res (1979) 1.07
Bacterial invasion of the periodontium in a case of juvenile periodontitis. J Clin Periodontol (1982) 1.06
Transendothelial transport (transcytosis) of iron-transferrin complex in the bone marrow. J Ultrastruct Res (1984) 1.06
Fate of the nucleus of the marrow erythroblast. Science (1973) 1.06
Differential response of bone marrow and extramedullary adipose cells to starvation. Experientia (1974) 1.06
The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Oncogene (1994) 1.05
Orofacial presentations of sarcoidosis--a case series and review of the literature. Br Dent J (2008) 1.04
Inactivation of a transfected gene in human fibroblasts can occur by deletion, amplification, phenotypic switching, or methylation. Mol Cell Biol (1987) 1.04
Anatomical hazards to the passage of erythrocytes through the spleen. Semin Hematol (1970) 1.04